Endometriosis is very often found in areas near the end of the
fallopian tube and in the cul de sac behind the uterus (as well
as other dependent regions of the pelvis). This distribution of
sites has suggested that retrograde flow (from the uterus through
the tube into the pelvis) of menstrual blood and cellular material
during menses is an important cause of endometriosis.
There are three main theories describing mechanisms which may
cause endometriosis. These include
- retrograde flow,
- vascular spread and
- metaplasia of the coelomic epithelium.
Each theory has many supporters. It may be that each of these
three theories may accurately describe one of several possible
mechanisms. Additionally, an alteration in the immune system (often
subtle abnormalities are noted in endometriosis patients) may
assist the development of endometriosis in the presence of one
of these inciting causes.
In the 1920s a physician named John Sampson devoted a great deal
of time to the study of endometriosis and is widely credited with
the initial suggestion that retrograde flow is the primary
path for this tissue to grow in the pelvis. His reasoning was
based on the distribution of implants that he observed.
Additional support for Sampson's theory has been collected over
the years and includes
- virtually all women undergoing laparoscopy at the time of
menses can be seen to have blood flowing from the fimbriated end
of their fallopian tubes (retrograde flow)
- the most common sites for endometriosis at both laparotomy
and laparoscopy are in dependent portions of the pelvis and close
to the ends of the tubes
- when recovered surgically and grown in culture endometrial
fragments within menstrual blood have the potential to survive
and grow
- a higher incidence of endometriosis is observed in women who
have obstructions to the normal downward flow (out through the
vagina), forcing a greater percentage of flow through the tube
in a retrograde fashion
- there is an increased risk of endometriosis if the woman has
a shorter intermenstrual interval, longer duration flow or larger
volume of flow
- in female monkeys where the uterus has been surgically transposed
(turned around) so that the flow is predominantly into the abdomen
rather than out the vagina there is a higher incidence of endometriosis
One interesting question regarding this information is
"if virtually all women have retrograde flow of endometrial
cells into their pelvis during each menses then why don't virtually
all women have endometriosis?"
The answer to this question is not known, however, there are several
proposed theories. The most widely accepted theory concerns the
immune system. Basically, the immune system can be thought of
as a housekeeping mechanism that rejects or destroys any tissue
that is "foreign." It can also regulate where a tissue
will be allowed to grow within the body.
When the immune system is activated an inflammatory response occurs
and these inflammatory cells help to reject the abnormally placed
tissues. If there is a problem with the immune response then tissue
might be allowed to grow in abnormal locations, that is, to form
implants such as endometriosis. In theory, if the amount of tissue
is very large it may overwhelm the available normally functioning
immune response and result in the growth of this tissue in abnormal
locations. Therefore, endometriosis may occur either when a defective
immune system is presented with a normal amount of retrograde
flow or a normal immune system is presented with a large amount
of tissue.
The presence of endometriosis in sites distant from the adnexae
(ovaries and tubes) has led to alternate theories.
Vascular spread of endometrial tissue (via the blood vessels
or lymphatics supplying the uterus) from the uterus to distant
sites may allow this tissue to be transported to areas like the
lungs or the knee. Certainly, the uterine walls are highly vascularized
and endometrial tissue might find entrance through damaged vessels,
such as those that are "broken" during the course of
menstrual flow. Direct evidence supporting the ability for endometrial
implants to be transported through the vascular system to distant
sites where they might implant came in 1981 when diced endometrial
tissue from a rabbit was experimentally placed into the vein of
the animal's ear and endometriosis implants then developed in
the animal's lungs.
Metaplasia (change from one normal type of tissue to another
normal type of tissue) of the coelomic epithelium (type
of tissue lining the pelvic structures where endometriosis is
commonly found and from which uterine endometrial cells are normally
derived) allows endometrial tissue to replace other types of tissues
outside the uterus. This theory is indirectly supported by the
finding of endometriosis in some men who have received estrogen
treatments, where no endometrial tissue normally exists. Further
support that is more direct comes from research in which rabbit
endometrial tissue placed in a diffusion chamber (which does not
allow the tissue to leave the chamber but does allow chemical
substances produced by the endometrium to leave the chamber) was
implanted surgically below the peritoneal lining in these rabbits
and some time later excised tissue surrounding these implants
were found to have endometriosis like changes. This research
suggests that something made by these tissues rather than the
tissues themselves may be responsible for endometriosis.
Immunologic defects have been found in women with endometriosis.
Both cell mediated and humoral immunologic defects have been noted.
Cell mediated abnormalities are suggested by a decrease in cell
lysis (cell death) during cytotoxicity assays in women with severe
endometriosis as compared to control women. Humoral defects are
suggested by the finding of autoantibodies (IgG and IgA types)
directed against endometrial tissue in the blood and peritoneal
fluids of women with endometriosis. Autoantibodies directed against
subcellular components (like phospholipids in the cell walls,
possibly resulting in an "anti-phospholipid syndrome")
have also been identified in women with endometriosis. The antiphospholipid
syndrome is associated with recurrent pregnancy loss (see this
other separate section for more information on this syndrome)
|